@gennisium.com
Suitable solutions for preterm infants
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Gennisium is a pharmaceutical brand dedicated to the health and well-being of newborns. According to the World Health Organization, 15 million babies are born prematurely each year, with preterm birth being the leading cause of neonatal death globally. Gennisium recognizes the urgent need for specific treatments and prophylactic therapies for premature infants, as current solutions are often derived from adult treatments.
Our goal is to provide all newborns, regardless of their country of birth, access to our innovative products. As a newly established organization, Gennisium manages key functions in-house, including Regulatory Affairs, Medical and Marketing, and Commercialization. We also control our Pharmaceutical and Distribution activities by combining in-house and outsourcing operations to ensure flexibility and cost-effectiveness.
Our experienced team has a proven track record in managing regulatory processes, partnering with other organizations, and expanding our reach beyond the European Union. At Gennisium, we are committed to working with a network of suppliers and consultants to develop and manufacture our products, ensuring the highest quality standards. We are driven by our vision to improve the lives of preterm infants worldwide and provide them with the care they need for healthy development
Company Type
Privately Held
Company Size
2-10
Year Founded
2018
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories